Fibrillar amyloid-β affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration

Acta Neuropathologica

Volumn 101, Issue 6, 2001, Pages 585-590

  Wegiel, J ^a   Bobinski, M ^a   Tarnawski, M ^a   Dziewiatkowski, J ^a   Popovitch, E ^a   Miller, D C ^a   Wisniewski, T ^a   Golomb, J ^a   de Leon, M J ^a   Reisberg, B ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer disease; Amyloidosis beta; Fibrillar plaques; Morphometry; Neocortex; Neurofibrillary degeneration

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN; THIOFLAVINE;

AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BRAIN CORTEX; CELL ACTIVITY; CELL COUNT; CELL DENSITY; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULA; MENTAL DETERIORATION; NEOCORTEX; NERVE CELL; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NEURITE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPATHOLOGY; OCCIPITAL CORTEX; PAIRED HELICAL FILAMENT; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RATING SCALE; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; BRAIN; FEMALE; HUMANS; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; SENILE PLAQUES;

EID: 0034914189     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000334     Document Type: Article

References (60)

1. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer disease
2. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: A rare subtype in very old subjects
3. Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study of Dementia
4. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects
5. Atrophy of the hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease
6. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease
7. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease
8. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
9. Neuropathological staging of Alzheimer-related changes
10. Frequency of stages of Alzheimer-related lesions in different age categories
11. Allocortical neurofibrillary changes in progressive supranuclear palsy
12. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism dementia complex of Guam: Immunochemical characterization of tau proteins
13. Neurofibrillary tangles in chronic alcoholics
14. β-Amyloid "load" correlates with severity of Alzheimer's dementia: Quantification via image analysis
15. Large amounts of neocortical βA4 deposits without Alzheimer changes in a nondemented case
16. Identification of normal and pathological aging in prospectively studied nondemented elderly humans
17. Correlations of synaptic and pathological markers with cognition of the elderly
18. Does amyloid precede paired helical filaments in the senile plaque? A study of 15 cases with graded intellectual status in aging and Alzheimer disease
19. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type
20. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of postencephalic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex
21. Gerstmann-Straussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP amyloid coexist in an affected family
22. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease
23. Multiple isoform of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
24. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain
25. Parkinsonism dementia complex in endemic disease on the island of. Guam Pathological features
26. Amyloid, dementia and Alzheimer's disease
27. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
28. Alzheimer's disease: An electron microscopical study
29. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration
30. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
31. Alzheimer neurofibrillary change in subacute sclerosing panencephalitis
32. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein in Alzheimer's disease
33. Neuritic pathology and dementia in Alzheimer's disease
34. Making the diagnosis of Alzheimer disease
35. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain
36. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: Correlations using three sets of neuropathological criteria
37. Constructional apraxia in Alzheimer's disease correlates with neuritic neuropathology in occipital cortex
38. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes
39. Filaments of Pick's bodies contain altered cytoskeletal elements
40. The distributions of tangles, plaques, and related immunocytochemical markers in healthy aging and Alzheimer's disease
41. Senile plaque neurites fail to demonstrate anti-paired helical filament and anti-microtubule-associated protein tau immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex
42. Functional Assessment Staging (FAST)
43. The Global Deterioration Scale for assessment of primary degenerative dementia
44. Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer disease
45. Frequency of stages of Alzheimer-related lesions in different age categories
46. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles
47. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
48. The neuropathology of Alzheimer's disease - Issues in need of resolution
49. Region- and cell-type specific pattern of tau phosphorylation in dog brain
50. Neuronal loss and amyloid-β removal in the amygdala of people with Down syndrome
51. Microglial cells are the driving force in fibrillar plaque formation whereas astrocytes are a leading factor in plaque degradation
52. Shift from fibrillar to nonfibrillar Aβ deposits in the neocortex of subjects with Alzheimer disease
53. The role of microglial cells and astrocytes in fibrillar plaques evolution in transgenic APPsw mice
54. Plaques, tangles and dementia. A quantitative study
55. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease
56. Neuritic and amyloid plaques in senile dementia of the Alzheimer type
57. Reexamination of the pathogenesis of the senile plaque
58. Ultrastructural studies of the cells forming amyloid fibers in classical plaques
59. Neurofibrillary pathology in subacute sclerosing panencephalitis
60. Age-associated development of diffuse and thioflavine-S-positive plaques in Down syndrome